Tech Company Inital Public Offerings

Shattuck Labs IPO

Operating out of Durham, Shattuck Labs is now a public company.

Transaction Overview

Company Name
Announced On
10/8/2020
Transaction Type
IPO
Amount
$202,300,000
Proceeds Purpose
Per the firm's most recent regulatory filing, it plans to use the net proceeds as follows:to advance SL-172154 through the completion of our ongoing and planned Phase 1 clinical trials and to commence a Phase 2 clinical program;to advance SL-279252 through the completion of our ongoing Phase 1 clinical trial; andto develop and advance additional product candidates derived from our platforms through IND-enabling studies and to commence Phase 1 clinical trials.the remainder of the net proceeds for working capital and general corporate purposes.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
21 Parmer Way 200
Durham, NC 27709
USA
Overview
Shattuck (Nasdaq: STTK) is developing a breakthrough platform for immunotherapy, which harnesses the human immune system to improve outcomes for patients battling cancer and inflammatory disease. Shattuck's proprietary technology represents the next evolutionary step in cancer therapy by endowing one molecule with multiple, synergistic functions.
Profile
Shattuck Labs LinkedIn Company Profile
Social Media
Shattuck Labs Company Twitter Account
Company News
Shattuck Labs News
Facebook
Shattuck Labs on Facebook
YouTube
Shattuck Labs on YouTube

Management Team

Title
Name
Email & Social
Chairman
Josiah Hornblower
  Josiah Hornblower LinkedIn Profile  Josiah Hornblower Twitter Account  Josiah Hornblower News  Josiah Hornblower on Facebook
Chief Executive Officer
Taylor Schreiber
  Taylor Schreiber LinkedIn Profile  Taylor Schreiber Twitter Account  Taylor Schreiber News  Taylor Schreiber on Facebook
Chief Medical Officer
Lini Pandite
  Lini Pandite LinkedIn Profile  Lini Pandite Twitter Account  Lini Pandite News  Lini Pandite on Facebook
Vice President
Fatima Rangwala
  Fatima Rangwala LinkedIn Profile  Fatima Rangwala Twitter Account  Fatima Rangwala News  Fatima Rangwala on Facebook
VP - Bus. Development
Casi DeYoung
  Casi DeYoung LinkedIn Profile  Casi DeYoung Twitter Account  Casi DeYoung News  Casi DeYoung on Facebook
VP - Bus. Development
Andrew Neill
  Andrew Neill LinkedIn Profile  Andrew Neill Twitter Account  Andrew Neill News  Andrew Neill on Facebook
VP - General Counsel
Erin Thomson
  Erin Thomson LinkedIn Profile  Erin Thomson Twitter Account  Erin Thomson News  Erin Thomson on Facebook
VP - Manufacturing
James Stout
  James Stout LinkedIn Profile  James Stout Twitter Account  James Stout News  James Stout on Facebook
VP - Product Management
Suresh de Silva
  Suresh de Silva LinkedIn Profile  Suresh de Silva Twitter Account  Suresh de Silva News  Suresh de Silva on Facebook
VP - R & D
George Fromm
  George Fromm LinkedIn Profile  George Fromm Twitter Account  George Fromm News  George Fromm on Facebook
VP - Regulatory Affairs
Thomas Lampkin
  Thomas Lampkin LinkedIn Profile  Thomas Lampkin Twitter Account  Thomas Lampkin News  Thomas Lampkin on Facebook


 

 

Browse more venture capital transactions:

Prev: 10/8/2020: Shogun venture capital transaction
Next: 10/8/2020: Redaptive venture capital transaction

 

Share this article

 


Where The Data Comes From

Our team works diligently to document every notable VC transaction. VC transactions reported here come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary